title: Successful explant of a continuous-flow left ventricular assist device after two years of circulatory support.
authors.affiliation: Advanced Heart Failure and Cardiac Transplant Service, Royal Perth Hospital, Perth, Western Australia, Australia. jay.baumwol@health.wa.gov.au.
authors.forename: Jay
authors.initials: J
authors.lastname: Baumwol
authors.forename: Kaitlyn
authors.initials: K
authors.lastname: Lam
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Maiorana
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000503:physiopathology / Q000534:rehabilitation / Q000601:surgery*; D004232:Diuretics / Q000627:therapeutic use; D005080:Exercise Test; D006352:Heart Ventricles / Q000187:drug effects / Q000503:physiopathology / Q000601:surgery*; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D004232:Diuretics; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D013148:Spironolactone; C081643:candesartan